What is Akebia Therapeutics Inc. (AKBA) Stock Return on Shareholders’ Capital?

With 3.81 million shares changed hands, the volume of the stock remained lighter than its average volume of 4.78 million shares. The 52-week range on AKBA shows that it touched its highest point at $2.48 and its lowest point at $0.59 during that stretch. It currently has a 1-year price target of $5.00. Beta for the stock currently stands at 0.88.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AKBA was down-trending over the past week, with a drop of -9.15%, but this was up by 1.46% over a month. Three-month performance dropped to -10.32% while six-month performance rose 49.46%. The stock gained 118.35% in the past year, while it has gained 12.10% so far this year. A look at the trailing 12-month EPS for AKBA yields -0.28 with Next year EPS estimates of -0.27. For the next quarter, that number is -0.07. This implies an EPS growth rate of 0.32% for this year and 1.92% for next year.

Float and Shares Shorts:

At present, 194.58 million AKBA shares are outstanding with a float of 186.68 million shares on hand for trading. In addition to AKBA as the firm’s Akebia Therapeutics, Inc., AMBA serves as its Ambarella, Inc.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AKBA since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.

Dividends & Yield:

In terms of dividends, AKBA has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and AKBA currently yields $0.00. In the past year, AKBA’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, AKBA has a current buyback yield of $–. This was $– for the TTM, and it was $– for the past five years.